allcancercure.com

The Centre hospitalier de l’Universite de Montreal (CHUM) announces the beginning of a phase II randomized double blind trial with the potential of providing a therapeutic alternative after a first acute myocardial infarction. One patient has already undergone this technique, which consists of implanting immature stem cells from the bone marrow to regenerate heart muscle. [...]

A paper in the latest issue of Menopause International argues that women with cardiovascular disease (CVD) have a worse outcome and are more likely to die than men once diagnosed. CVD is the most common cause of death in women, yet there is a tendency to assume that it is a disease more likely to [...]

Sunitinib-a tyrosine-kinase inhibitor used to extend survival in patients with renal-cell carcinoma and gastrointestinal stromal tumours-has cardiotoxic effects. As such, patients given sunitinib, especially those with cardiac risk factors-need to be closely monitored. These are the conclusions of authors of an Article published in this week’s edition of The Lancet. Dr Ming Hui Chen, Cardiology [...]

Frost & Sullivan recently published research results on the state of adoption for atrial fibrillation therapies in the U.S. cardiovascular market. Through more than 150 detailed interviews with electrophysiologists, cardiologists and other cardiovascular professionals, the company determined key drivers and obstacles involving the adoption and utilization of various atrial fibrillation (AFib) treatments. In this study, [...]

Chest pain is still the most common sign of a heart attack for most women, although studies have shown that women are more likely than men to have symptoms other than chest pain or discomfort when experiencing a heart attack or other form of acute coronary syndrome (ACS), according to an article “Symptom Presentation of [...]

The Sorin Group (MIL:SRN), the largest European cardiovascular company and world leader in medical technologies for cardiac surgery, announced the first commercial implant of the Mitroflow Aortic Pericardial Heart ValveTM in the United States, performed by the Cardiovascular Surgery Division at Mayo Clinic in Rochester, Minnesota. Designed to provide superior hemodynamic performance and ease of [...]

If a person has a heart attack and receives transplanted genetically engineered cells, his/her chances of suffering from abnormal heart rhythm (ventricular tachycardia) later are significantly reduced. Ventricular tachycardia is the most common cause of sudden death following a heart attack. You can read about this in the latest issue of Nature. Scientists managed to [...]

Rapid diagnostic testing used to check for the presence of prion diseases such as “mad cow disease” might fail to identify some highly infectious samples, researchers have found. Currently, scanning beef or other meat products for possible prion infection involves sampling brain tissue from the animal for abnormally folded prion protein, also called PrP; this [...]

New results announced at TCT continue to demonstrate that Boston Scientific’s drug-eluting stents (DES) are just as safe as and more effectiafeve than bare-metal stents (BMS) when used according with their Directions for Use. As Safe As A BMS – In more than 61,000 patients in seven real world registries, five (ASAN,1 MIDAS,2 Ontario,3 S.T.E.N.T4 [...]

Berlin Heart announced the first patient enrolment in the prospective IDE study for its EXCOR(R) Paediatric VAD, a mechanical cardiac support system for critically ill Paediatric patients suffering from severe heart failure. The multi-center IDE study is to evaluate the safety and probable benefit of using the EXCOR(R) Paediatric VAD to support Paediatric patients. The [...]